Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Liechtenstein
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Italy
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
United Kingdom
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
France
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Spain
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Germany
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y
Switzerland
04710659.6
Filed on 2004-02-12
04710659.6
Filed on 2004-02-12
Methods of Producing and Using Regulatory B-Cells
US Patent 9,629,897
Filed on 2014-10-23
Filed on 2014-10-23
Methods of Producing and Using Regulatory B-Cells
Japan
2015-509008
Filed on 2014-10-24
2015-509008
Filed on 2014-10-24
Methods of Producing and Using Regulatory B-Cells
European Patent
13718448.7
Filed on 2013-04-11
13718448.7
Filed on 2013-04-11